Literature DB >> 27687811

Dyslipidemia: Obese or Not Obese-That Is Not the Question.

David H Ipsen1, Pernille Tveden-Nyborg1, Jens Lykkesfeldt2.   

Abstract

PURPOSE OF REVIEW: Purpose of review: It is becoming increasingly clear that some obese individuals do not develop dyslipidemia and instead remain healthy, while some normal weight individuals become dyslipidemic and unhealthy. RECENT
FINDINGS: The present review examines the similarities and differences between healthy and unhealthy individuals with and without obesity and discusses putative underlying mechanisms of dyslipidemia. The presence of dyslipidemia and compromised metabolic health in both lean and obese individuals suggests that the obese phenotype per se does not represent a main independent risk factor for the development of dyslipidemia and that dyslipidemia, rather than obesity, may be the driver of metabolic diseases. Notably, adipose tissue dysfunction and ectopic lipid deposition, in particular in the liver, seems a common trait of unhealthy individuals.

Entities:  

Keywords:  Dyslipidemia; Metabolically healthy obese; Metabolically unhealthy normal weight; Metabolically unhealthy obese; Obesity

Mesh:

Substances:

Year:  2016        PMID: 27687811     DOI: 10.1007/s13679-016-0232-9

Source DB:  PubMed          Journal:  Curr Obes Rep        ISSN: 2162-4968


  72 in total

1.  The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome.

Authors:  Kitt Falk Petersen; Sylvie Dufour; David B Savage; Stefan Bilz; Gina Solomon; Shin Yonemitsu; Gary W Cline; Douglas Befroy; Laura Zemany; Barbara B Kahn; Xenophon Papademetris; Douglas L Rothman; Gerald I Shulman
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-18       Impact factor: 11.205

2.  Fetuin-A: the missing link in lipid-induced inflammation.

Authors:  Jan Heinrichsdorff; Jerrold M Olefsky
Journal:  Nat Med       Date:  2012-08       Impact factor: 53.440

3.  Induction of regulatory T cells decreases adipose inflammation and alleviates insulin resistance in ob/ob mice.

Authors:  Yaron Ilan; Ruth Maron; Ann-Marcia Tukpah; Tatiani Uceli Maioli; Gopal Murugaiyan; Kaiyong Yang; Henry Yim Wu; Howard L Weiner
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-05       Impact factor: 11.205

4.  Interleukin 6 reduces lipoprotein lipase activity in adipose tissue of mice in vivo and in 3T3-L1 adipocytes: a possible role for interleukin 6 in cancer cachexia.

Authors:  A S Greenberg; R P Nordan; J McIntosh; J C Calvo; R O Scow; D Jablons
Journal:  Cancer Res       Date:  1992-08-01       Impact factor: 12.701

Review 5.  Normal weight dyslipidemia: Is it all about the liver?

Authors:  David Højland Ipsen; Pernille Tveden-Nyborg; Jens Lykkesfeldt
Journal:  Obesity (Silver Spring)       Date:  2016-02-12       Impact factor: 5.002

6.  Insulin resistance affects the regulation of lipoprotein lipase in the postprandial period and in an adipose tissue-specific manner.

Authors:  D Panarotto; P Rémillard; L Bouffard; P Maheux
Journal:  Eur J Clin Invest       Date:  2002-02       Impact factor: 4.686

Review 7.  The role of hepatokines in metabolism.

Authors:  Norbert Stefan; Hans-Ulrich Häring
Journal:  Nat Rev Endocrinol       Date:  2013-01-22       Impact factor: 43.330

8.  Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity.

Authors:  Elisa Fabbrini; Faidon Magkos; B Selma Mohammed; Terri Pietka; Nada A Abumrad; Bruce W Patterson; Adewole Okunade; Samuel Klein
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-24       Impact factor: 11.205

9.  The role of interleukin 1β in the anti-adipogenic action of macrophages on human preadipocytes.

Authors:  Annemarie Gagnon; Charlie Foster; Anne Landry; Alexander Sorisky
Journal:  J Endocrinol       Date:  2013-04-15       Impact factor: 4.286

10.  Individuals with Metabolically Healthy Overweight/Obesity Have Higher Fat Utilization than Metabolically Unhealthy Individuals.

Authors:  Arturo Pujia; Carmine Gazzaruso; Yvelise Ferro; Elisa Mazza; Samantha Maurotti; Cristina Russo; Veronica Lazzaro; Stefano Romeo; Tiziana Montalcini
Journal:  Nutrients       Date:  2016-01-04       Impact factor: 5.717

View more
  7 in total

1.  Combined Effects of Obesity and Dyslipidaemia on the Prevalence of Diabetes Amongst Adults Aged ≥45 Years: Evidence from a Nationally Representative Cross-Sectional Study.

Authors:  Simin Zhang; Donghan Sun; Xiaoyi Qian; Li Li; Wenwen Wu
Journal:  Int J Environ Res Public Health       Date:  2022-06-30       Impact factor: 4.614

Review 2.  Does dietary fat affect inflammatory markers in overweight and obese individuals?-a review of randomized controlled trials from 2010 to 2016.

Authors:  Vibeke H Telle-Hansen; Jacob J Christensen; Stine M Ulven; Kirsten B Holven
Journal:  Genes Nutr       Date:  2017-10-04       Impact factor: 5.523

3.  Fatty acid profile and estimated desaturase activities in whole blood are associated with metabolic health.

Authors:  Karianne Svendsen; Thomas Olsen; Tove C Nordstrand Rusvik; Stine M Ulven; Kirsten B Holven; Kjetil Retterstøl; Vibeke H Telle-Hansen
Journal:  Lipids Health Dis       Date:  2020-05-21       Impact factor: 3.876

4.  The impact on high-grade serous ovarian cancer of obesity and lipid metabolism-related gene expression patterns: the underestimated driving force affecting prognosis.

Authors:  Mauricio A Cuello; Sumie Kato; Francisca Liberona
Journal:  J Cell Mol Med       Date:  2017-12-20       Impact factor: 5.310

Review 5.  Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease.

Authors:  David Højland Ipsen; Jens Lykkesfeldt; Pernille Tveden-Nyborg
Journal:  Cell Mol Life Sci       Date:  2018-06-23       Impact factor: 9.261

6.  Level of Control of Dyslipidemia Among Patients Followed in Family Medicine Clinics in Riyadh, Saudi Arabia.

Authors:  Amal Hadi; Mohammed A AlAteeq
Journal:  Cureus       Date:  2021-06-07

7.  Physical Activity and BMI before and after the Situation Caused by COVID-19 in Upper Primary School Pupils in the Czech Republic.

Authors:  Jana Pyšná; Ladislav Pyšný; David Cihlář; Dominika Petrů; Lenka Hajerová Müllerová; Luděk Čtvrtečka; Anna Čechová; Jiří Suchý
Journal:  Int J Environ Res Public Health       Date:  2022-03-05       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.